Abbott India Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter

The Abbott India Q2 results FY27 announcement is the next scheduled earnings event for Abbott India Ltd., the listed Indian subsidiary of Abbott, selling branded pharmaceutical formulations across gastroenterology, women's health, metabolics and central nervous system therapies. The stock traded at Rs 25,555.00 on the NSE on 8 September 2026, down 1.48% from the previous close of Rs 25,940.00, about 19.2% below its 52-week high of Rs 31,645.00 and 1.6% above its 52-week low of Rs 25,150.00.

What makes the Abbott India Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 1,757.00 crore of revenue and a profit of Rs 415.00 crore, while the most recent quarter on record, Q1 FY27, produced Rs 1,814.00 crore and a profit of Rs 429.00 crore. Everything below is built from those reported figures rather than from any forecast.

Click Here – Get Free Investment Predictions

When Is the Abbott India Q2 Results FY27 Date?

The Abbott India Q2 results date for FY27 is not confirmed. As of 8 September 2026, Abbott India Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.

What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Abbott India Q2 results date becomes public through that filing rather than through any advance announcement.

The Abbott India Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Abbott India.

Abbott India Q2 Results Expectations: What the Market Is Actually Tracking

No verified analyst estimate for the Abbott India Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Abbott India. The Abbott India Q2 results watchlist below is built from what the company has actually reported and disclosed.

The first is the September 2025 base of Rs 415 crore, the strongest profit quarter of the last five before June. Beating it requires genuine growth rather than the modest sequential improvement that has characterised recent quarters.

The second is price growth versus volume. Abbott India sells branded formulations where a large share of growth comes from price and new launches rather than volume, and the split decides how durable the margin is.

The third is the narrow revenue band. The top line has moved between Rs 1,710 crore and Rs 1,814 crore across five quarters, so this is a business that compounds slowly and steadily rather than one that surprises.

Check Abbott India Ltd. Live Fundamentals on the Univest Screener

Abbott India Q2 Results Preview: The Q1 FY27 Actuals It Builds On

Abbott India Ltd. reported revenue of Rs 1,814.00 crore in Q1 FY27, up 4.37% from Rs 1,738.00 crore in Q1 FY26, and a profit of Rs 429.00 crore at the net level, up 17.21% from Rs 366.00 crore in Q1 FY26. These are reported actuals, not estimates.

Sequentially, revenue was up 6.08% over the March 2026 quarter figure of Rs 1,710.00 crore, and net profit was up 8.61% from Rs 395.00 crore in Q4 FY26. Operating margin stood at 29.5% in Q1 FY27 against 31.0% in the September 2025 quarter, which is the comparison the Abbott India Q2 results print will be read against.

Q2 FY26 Base: The Comparison Abbott India Q2 Results FY27 Must Beat

Abbott India Ltd. reported revenue of Rs 1,757.00 crore and a profit of Rs 415.00 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Abbott India Q2 results preview.

Net profit in that base quarter was below the Rs 429.00 crore just reported for Q1 FY27, so the year-on-year comparison starts from a manageable level. Revenue of Rs 1,757.00 crore sits below the Rs 1,814.00 crore of the June 2026 quarter, which frames how much sequential movement the Abbott India Q2 results print needs to show growth.

Abbott India Quarterly Results Trend Over the Last Four Quarters

Quarter	Revenue (Rs Cr)	Net Profit (Rs Cr)
Q2 FY26 (Sep 2025)	1,757.00	415.00
Q3 FY26 (Dec 2025)	1,724.00	376.00
Q4 FY26 (Mar 2026)	1,710.00	395.00
Q1 FY27 (Jun 2026)	1,814.00	429.00

Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company's exchange filings, and they are the only basis this Abbott India Q2 results preview uses.

Revenue across those four quarters ranged from Rs 1,710.00 crore to Rs 1,814.00 crore, and net profit from Rs 376.00 crore to Rs 429.00 crore. That spread is the honest context for the Abbott India Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.

Key Factors That Could Shape Abbott India Q2 Results FY27

The Abbott India Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Abbott India has already reported.

Branded Formulation Pricing

Growth in India's branded generics market comes substantially from price increases within regulatory limits and from new product introductions. Any change in the National List of Essential Medicines coverage affects the pricing headroom directly.

Therapy Mix and New Launches

Gastroenterology, women's health and metabolics behave differently through the year. The therapy contribution disclosed alongside results explains margin movement better than the consolidated revenue line does.

Debt-Free Balance Sheet and High Returns

Abbott India carries no debt, a return on equity of 34.40% and a dividend yield of 2.05%. The stock trades at a price-to-earnings ratio of 34.08 against a sector average of 37.70, but sits near its 52-week low of Rs 25,150.00 after a long slide.

Abbott India Q2 Results FY27: Share Price and Valuation Going Into the Print

Abbott India share price today is Rs 25,555.00 on the NSE, down Rs 385.00 or 1.48% from the previous close of Rs 25,940.00 on 8 September 2026, ahead of the Abbott India Q2 results announcement.

Metric	Value (8 September 2026)
NSE Symbol	ABBOTINDIA
Current Market Price	Rs 25,555.00
52-Week High	Rs 31,645.00
52-Week Low	Rs 25,150.00
Market Capitalisation	Rs 55,030 crore
PE Ratio	34.08
Sector PE	37.70
PB Ratio	11.53
EPS (TTM)	Rs 749.86
Book Value per Share	Rs 2,247.00
Debt to Equity	0.00
Return on Equity	34.40%
50-Day Moving Average	Rs 27,083.50
200-Day Moving Average	Rs 27,114.15
RSI (14)	33.87

The stock trades below both its 50-day average of Rs 27,083.50 and its 200-day average of Rs 27,114.15, with a 14-day RSI of 33.87. None of this is a view on where the shares go once the Abbott India Q2 results are announced, and no price target is offered here.

Download the Univest iOS App or Univest Android App to track Abbott India Ltd. live price and quarterly earnings updates.

What Investors Should Watch When Abbott India Q2 Results Are Announced

Four lines carry most of the information in a company of this size, and reading them in order keeps the Abbott India Q2 results print in proportion.

1. Revenue against the Rs 1,757.00 crore reported in the September 2025 base quarter
2. Net profit against a profit of Rs 415.00 crore in that same quarter
3. Operating margin against 29.5% in Q1 FY27
4. Any exceptional item, provision or one-off gain disclosed alongside the numbers

A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Abbott India Q2 results announcement should be read together with the notes to the results rather than the headline alone.

Conclusion on Abbott India Q2 Results FY27

The Abbott India Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Abbott India Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.

On that basis the Abbott India Q2 results FY27 print faces a base of Rs 1,757.00 crore in revenue and a profit of Rs 415.00 crore, with the most recent quarter having delivered Rs 1,814.00 crore and a profit of Rs 429.00 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Abbott India, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.

FAQs on Abbott India Q2 Results FY27

What is the Abbott India Q2 results date for FY27?

Ans. The Abbott India Q2 results date for FY27 is not confirmed. Abbott India Ltd. had not filed a board meeting intimation with the NSE or BSE as of 8 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.

What quarter do the Abbott India Q2 results 2026 cover?

Ans. The Abbott India Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Abbott India Ltd. reports revenue, operating profit and net profit for that period, and the Abbott India Q2 results filing also carries the notes to the accounts.

What were the Abbott India Q1 FY27 results?

Ans. Abbott India Ltd. reported revenue of Rs 1,814.00 crore in Q1 FY27 and a profit of Rs 429.00 crore at the net level. Revenue was up 4.37% versus Q1 FY26 and net profit was up 17.21% from Rs 366.00 crore in Q1 FY26.

What were Abbott India Q2 FY26 results in the September 2025 quarter?

Ans. Abbott India Ltd. reported revenue of Rs 1,757.00 crore and a profit of Rs 415.00 crore in Q2 FY26. Operating margin was 31.0%. Those figures form the base for the Abbott India Q2 results FY27 comparison.

What are the main Abbott India Q2 results expectations this quarter?

Ans. No verified analyst estimate is publicly available. The Abbott India Q2 results expectations centre on revenue against the Rs 1,757.00 crore base, net profit against a profit of Rs 415.00 crore, operating margin against 29.5% in Q1 FY27, and any exceptional item disclosed with the numbers.

What is Abbott India share price today ahead of the Q2 earnings?

Ans. Abbott India share price is Rs 25,555.00 on the NSE as of 8 September 2026, down 1.48% from Rs 25,940.00. The stock is about 19.2% below its 52-week high of Rs 31,645.00 and 1.6% above its 52-week low of Rs 25,150.00, at a market capitalisation of Rs 55,030 crore.

Is Abbott India a good stock to buy before the Q2 results?

Ans. This article does not offer a buy, sell or hold recommendation on Abbott India Ltd.. The stock trades at a price-to-book ratio of 11.53 with a return on equity of 34.40%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.